RespireRx Pharmaceuticals Inc (fka RSPI)

[Ticonderoga221]

I expect Cortex will present data to the FDA, which will then review it and raise questions for Cortex at a formal meeting. What matters is whether Cortex can rebut the negative assumptions by presenting statistically compelling or verified data. The logical deductions you make might be valid, but are not sufficient.

This would not be the first time a company with a good product fails because its statistics, experiments or presentations are invalid.